◆英語タイトル：Orifarm Group AS - Strategic SWOT Analysis Review
◆商品コード：DATA904C4831
◆発行会社（調査会社）：
GlobalData
◆発行日：2018年8月
◆ページ数：22
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：デンマーク
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
Orifarm Group AS – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights
Orifarm Group A/S (Orifarm Group) is a parallel importer of pharmaceuticals and supplier of pharmaceuticals. It comprises of several companies engaged in the import, manufacture, re-packaging, distribution, registration and commercialization of pharmaceuticals in the UK, Scandinavia, Germany, Holland and Czech Republic. The company parallel imports pharmaceuticals from European (EU) countries and are sold in Sweden, Finland, Holland, Denmark, Norway, Germany and the UK. Orifarm Group also sells generic pharmaceuticals in the Nordics. It sells a range of generic over-the-counter (OTC) products under Taek gult and Tank Gult brands. Orifarm Group is headquartered in Odense, Denmark.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Orifarm Group A/S – Key Facts 5
Orifarm Group A/S – Key Employees 6
Orifarm Group A/S – Major Products and Services 7
Orifarm Group A/S – History 8
Orifarm Group A/S – Company Statement 9
Orifarm Group A/S – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Company Overview 11
Orifarm Group A/S – Business Description 12
Business Segment: Orifarm Generics Segment 12
Overview 12
Performance 12
Business Segment: Orifarm Parallel Import Segment 12
Overview 12
Performance 12
Orifarm Group A/S – Corporate Strategy 13
Orifarm Group A/S – SWOT Analysis 14
SWOT Analysis – Overview 14
Orifarm Group A/S – Strengths 14
Orifarm Group A/S – Weaknesses 15
Orifarm Group A/S – Opportunities 16
Orifarm Group A/S – Threats 17
Orifarm Group A/S – Key Competitors 18
Section 3 – Company’s Lifesciences Financial Deals and Alliances 19
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 19
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 20
Orifarm Group A/S, Recent Deals Summary 21
Section 4 – Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
Orifarm Group A/S, Key Facts 5
Orifarm Group A/S, Key Employees 6
Orifarm Group A/S, Major Products and Services 7
Orifarm Group A/S, History 8
Orifarm Group A/S, Subsidiaries 10
Orifarm Group A/S, Key Competitors 18
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 19
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 20
Orifarm Group A/S, Recent Deals Summary 21
List of Figures
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 19
Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 20
